Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection

Different programmed cell death-ligand 1 (PD-L1) assays and scoring algorithms are being used in the evaluation of PD-L1 expression for the selection of patients for immunotherapy in specific settings of advanced urothelial carcinoma (UC). In this paper, we sought to investigate three approved assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Munari, Enrico, Querzoli, Giulia, Brunelli, Matteo, Marconi, Marcella, Sommaggio, Marco, Cocchi, Marco A., Martignoni, Guido, Netto, George J., Caliò, Anna, Quatrini, Linda, Mariotti, Francesca R., Luchini, Claudio, Girolami, Ilaria, Eccher, Albino, Segala, Diego, Ciompi, Francesco, Zamboni, Giuseppe, Moretta, Lorenzo, Bogina, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363581/
https://www.ncbi.nlm.nih.gov/pubmed/35967344
http://dx.doi.org/10.3389/fimmu.2022.954910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363581/
https://www.ncbi.nlm.nih.gov/pubmed/35967344
http://dx.doi.org/10.3389/fimmu.2022.954910

Ejemplares similares